Bhatia's Addition Exemplifies Continued
Deployment of Resources Towards Building a
Leading Life Sciences Practice
NEW
YORK, June 24, 2024 /PRNewswire/ -- Oppenheimer
& Co. Inc. (Oppenheimer) — a leading investment bank,
wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY)
— announced today that Kunal Bhatia
joined as a Managing Director in the firm's Healthcare Investment
Banking Group. He will be based in New
York and report to Michael
Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head
of Healthcare Life Sciences Investment Banking.
"We are thrilled to welcome Kunal to the team," Margolis said.
"His unique combination of skills and industry contacts will be of
great value to Oppenheimer as we build on our momentum and focus on
serving as the investment bank of choice for healthcare and life
sciences clients in the U.S. and Europe."
Bhatia has extensive experience working with life sciences
companies across their lifecycle, and his coverage efforts
transcend multiple therapeutic areas. He has closely advised
management teams and boards through critical strategic and
financial initiatives and supported clients in navigating the
evolving healthcare capital markets.
He brings over 14 years of investment banking experience. Most
recently, Bhatia served as a Managing Director in the Healthcare
Investment Banking Group at TD Cowen, where he was integral to
advancing the firm's life sciences franchise since joining in 2016.
Prior to that, Bhatia served in various roles within investment
banking at RBC Capital Markets, Jefferies and Credit Suisse.
The recruitment of Bhatia closely follows Oppenheimer's
announcement of the further expansion of its European investment
banking footprint, with the addition of Martin Chamberlin as a Managing Director
and Head of European Healthcare based in London. Chamberlin joins Oppenheimer with over
20 years of experience.
"I am excited to join Oppenheimer and partner with the team to
drive the next phase of our growth," Bhatia said. "I have admired
the firm's long-standing track record of thought-leadership and
execution in life sciences. I look forward to contributing my
experience and connectivity across multiple regions to further
cement the strength of our Healthcare practice."
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc.
(Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc.
(OPY on the New York Stock Exchange), and its affiliates provide a
full range of wealth management, securities brokerage and
investment banking services to high net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
Media Contact:
Joseph
Kuo / Michael Dugan
Haven Tower Group LLC
424 317 4851 or 424 317 4852
jkuo@haventower.com or mdugan@haventower.com
View original
content:https://www.prnewswire.com/news-releases/oppenheimer-hires-kunal-bhatia-as-managing-director-healthcare-investment-banking-302178838.html
SOURCE Oppenheimer & Co. Inc.